INFECTIOUS VAGINITIS - SELECTING THERAPY AND PREVENTING RECURRENCE

被引:7
作者
GOODE, MA
GRAUER, K
GUMS, JG
机构
[1] UNIV FLORIDA, COLL MED,DEPT COMMUNITY HLTH & FAMILY MED, 624 SW 4TH AVE,POB 147001, GAINESVILLE, FL 32614 USA
[2] UNIV FLORIDA, COLL MED, DEPT P HARM PRACTICE, GAINESVILLE, FL 32614 USA
[3] UNIV FLORIDA, COLL MED, FAMILY MED RESIDENCY PROGRAM, GAINESVILLE, FL 32614 USA
[4] MED UNIV S CAROLINA, DEPT HOSP PHARM PRACTICE & ADM, CHARLESTON, SC 29425 USA
关键词
D O I
10.1080/00325481.1994.11945924
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vaginal candidiasis, trichomoniasis, and bacterial vaginosis can be difficult to manage because of predisposing factors and frequent recurrence. Thus, in addition to drug therapy, management should include attempts to minimize factors that contribute to recurrence. Both topical and oral agents are available for vaginal candidiasis and bacterial vaginosis, and both routes of administration appear equally safe and effective. Topical therapy may be used for these conditions in pregnant women. Only oral therapy is optimal for trichomoniasis. However, during pregnancy, the infection may be managed with topical clotrimazole. Currently, treatment of a woman's sexual partner is recommended in the management of trichomoniasis and is optional in cases of bacterial vaginosis. Sexual activity may also contribute to the recurrence of vaginal candidiasis; however, more studies are needed to evaluate the impact on recurrence rates of treating the male partner.
引用
收藏
页码:85 / +
页数:1
相关论文
共 45 条
[1]  
ALSALIHI FL, 1974, PEDIATRICS, V53, P196
[2]  
BALSDON MJ, 1980, LANCET, V1, P501
[3]   A FOLLOW-UP-STUDY OF METHODS OF CONTRACEPTION, SEXUAL-ACTIVITY, AND RATES OF TRICHOMONIASIS, CANDIDIASIS, AND BACTERIAL VAGINOSIS [J].
BARBONE, F ;
AUSTIN, H ;
LOUV, WC ;
ALEXANDER, WJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (02) :510-514
[4]  
BRAMMER KW, 1988, EUR J CLIN MICROBIOL, V7, P364, DOI 10.1007/BF01962338
[5]  
CAUWENBERGH G, 1987, CURR THER RES CLIN E, V41, P210
[6]   INEFFECTIVENESS OF ERYTHROMYCIN FOR TREATMENT OF HAEMOPHILUS-VAGINALIS-ASSOCIATED VAGINITIS - POSSIBLE RELATIONSHIP TO ACIDITY OF VAGINAL SECRETIONS [J].
DURFEE, MA ;
FORSYTH, PS ;
HALE, JA ;
HOLMES, KK .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (05) :635-637
[7]  
FRERICH W, 1977, CURR MED RES OPIN, V4, P640, DOI 10.1185/03007997709115284
[8]   HAEMOPHILUS VAGINALIS VAGINITIS - A NEWLY DEFINED SPECIFIC INFECTION PREVIOUSLY CLASSIFIED NONSPECIFIC VAGINITIS [J].
GARDNER, HL ;
DUKES, CD .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1955, 69 (05) :962-976
[9]  
GREAVES WL, 1988, OBSTET GYNECOL, V72, P799
[10]   METRONIDAZOLE FOR VAGINAL TRICHOMONIASIS - 7-DAY VS SINGLE-DOSE REGIMENS [J].
HAGER, WD ;
BROWN, ST ;
KRAUS, SJ ;
KLERIS, GS ;
PERKINS, GJ ;
HENDERSON, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 244 (11) :1219-1220